These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18221200)

  • 1. Protein kinase C pharmacology: perspectives on therapeutic potentials as antidementic and cognitive agents.
    Sun MK; Alkon DL
    Recent Pat CNS Drug Discov; 2006 Jun; 1(2):147-56. PubMed ID: 18221200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of protein kinase C activators: cognition-enhancing and antidementic therapeutics.
    Sun MK; Alkon DL
    Pharmacol Ther; 2010 Jul; 127(1):66-77. PubMed ID: 20382181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of protein kinase C isozymes for the treatment of dementias.
    Sun MK; Alkon DL
    Adv Pharmacol; 2012; 64():273-302. PubMed ID: 22840750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase C isozymes: memory therapeutic potential.
    Sun MK; Alkon DL
    Curr Drug Targets CNS Neurol Disord; 2005 Oct; 4(5):541-52. PubMed ID: 16266287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The "memory kinases": roles of PKC isoforms in signal processing and memory formation.
    Sun MK; Alkon DL
    Prog Mol Biol Transl Sci; 2014; 122():31-59. PubMed ID: 24484697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase C activators as synaptogenic and memory therapeutics.
    Sun MK; Alkon DL
    Arch Pharm (Weinheim); 2009 Dec; 342(12):689-98. PubMed ID: 19899099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PKC signaling deficits: a mechanistic hypothesis for the origins of Alzheimer's disease.
    Alkon DL; Sun MK; Nelson TJ
    Trends Pharmacol Sci; 2007 Feb; 28(2):51-60. PubMed ID: 17218018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effects of chronic bryostatin-1 and alpha-tocopherol on spatial learning and memory in rats.
    Sun MK; Alkon DL
    Eur J Pharmacol; 2008 Apr; 584(2-3):328-37. PubMed ID: 18313045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Protein kinase C].
    Matsushima H; Shimohama S
    Nihon Rinsho; 1995 May; 53(5):1282-6. PubMed ID: 7602792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein Kinase C Activation as a Potential Therapeutic Strategy in Alzheimer's Disease: Is there a Role for Embryonic Lethal Abnormal Vision-like Proteins?
    Talman V; Pascale A; Jäntti M; Amadio M; Tuominen RK
    Basic Clin Pharmacol Toxicol; 2016 Aug; 119(2):149-60. PubMed ID: 27001133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and differential distribution of the three major human protein kinase C isozymes (PKC alpha, PKC beta, and PKC gamma) of the central nervous system in normal and Alzheimer's disease brains.
    Clark EA; Leach KL; Trojanowski JQ; Lee VM
    Lab Invest; 1991 Jan; 64(1):35-44. PubMed ID: 1990207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bryostatin-1: pharmacology and therapeutic potential as a CNS drug.
    Sun MK; Alkon DL
    CNS Drug Rev; 2006; 12(1):1-8. PubMed ID: 16834754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for protein kinase C in associative learning.
    Olds JL; Alkon DL
    New Biol; 1991 Jan; 3(1):27-35. PubMed ID: 2039766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of protein kinase C isozymes in activation of human immunodeficiency virus type 1 in chronically infected promonocytic cells: evidence against a role of PKC beta 1.
    Kim CH; Lim SJ; Gollapudi S; Gupta S
    Biochem Biophys Res Commun; 1994 Feb; 199(1):292-7. PubMed ID: 8123026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase C-zeta activity but not level is decreased in Alzheimer's disease microvessels.
    Moore P; White J; Christiansen V; Grammas P
    Neurosci Lett; 1998 Sep; 254(1):29-32. PubMed ID: 9780084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin, PKC signaling pathways and synaptic remodeling during memory storage and neuronal repair.
    Nelson TJ; Sun MK; Hongpaisan J; Alkon DL
    Eur J Pharmacol; 2008 May; 585(1):76-87. PubMed ID: 18402935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ca2+-dependent and Ca2+-independent protein kinase C changes in the brain of patients with Alzheimer's disease.
    Matsushima H; Shimohama S; Chachin M; Taniguchi T; Kimura J
    J Neurochem; 1996 Jul; 67(1):317-23. PubMed ID: 8667008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase C-epsilon protects PC12 cells against methamphetamine-induced death: possible involvement of suppression of glutamate receptor.
    Uemura K; Aki T; Yamaguchi K; Yoshida Ki
    Life Sci; 2003 Feb; 72(14):1595-607. PubMed ID: 12551748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuated protein kinase C activity and translocation in Alzheimer's disease brain.
    Wang HY; Pisano MR; Friedman E
    Neurobiol Aging; 1994; 15(3):293-8. PubMed ID: 7936052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of protein kinase C isozymes by two-site enzyme immunoassay in human brains and changes in Alzheimer's disease.
    Shimohama S; Narita M; Matsushima H; Kimura J; Kameyama M; Hagiwara M; Hidaka H; Taniguchi T
    Neurology; 1993 Jul; 43(7):1407-13. PubMed ID: 8327146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.